Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth-Ann G Coller

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Opinion in Immunology|April 26, 2011
Dengue vaccines: progress and challengesBeth-Ann G Coller, David E Clements
Journal of Virology|February 2, 2024
Translational success of fundamental virology: a VSV-vectored Ebola vaccineElizabeth M Anderson, Beth-Ann G Coller
Idrugs : the Investigational Drugs Journal|December 15, 2010
Advances in flavivirus vaccine developmentBeth-Ann G Coller, David E Clements, Timothy Martyak, et al.
Vaccine|July 23, 2011
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced diseaseBeth-Ann G Coller, David E Clements, Andrew J Bett, et al.
Vaccines|December 23, 2020
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus DiseaseJoan G Tell, Beth-Ann G Coller, Sheri A Dubey, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 3, 2014
Advances in the understanding, management, and prevention of dengueLaura L Hermann, Swati B Gupta, Susan B Manoff, et al.
Vaccine|July 7, 2015
Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primatesDhanasekaran Govindarajan, Steven Meschino, Liming Guan, et al.
Viruses|March 27, 2025
Durability of Immunogenicity and Protection of rVSV∆G-ZEBOV-GP Vaccine in a Nonhuman Primate EBOV Challenge ModelSandra L Bixler, Amy C Shurtleff, Melek M E Sunay, et al.
The American Journal of Tropical Medicine and Hygiene|May 21, 2026
A Phase 1, Open Label, Safety Study of HBV-002 (West Nile Recombinant Subunit Vaccine) in Healthy AdultsBeth-Ann G Coller, David E Clements, Michele Yelmene, et al.
Vaccine|October 8, 2022
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trialsJakub K Simon, Stephen B Kennedy, Barbara E Mahon, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Opinion in Immunology|April 26, 2011
Dengue vaccines: progress and challengesBeth-Ann G Coller, David E Clements
Journal of Virology|February 2, 2024
Translational success of fundamental virology: a VSV-vectored Ebola vaccineElizabeth M Anderson, Beth-Ann G Coller
Idrugs : the Investigational Drugs Journal|December 15, 2010
Advances in flavivirus vaccine developmentBeth-Ann G Coller, David E Clements, Timothy Martyak, et al.
Vaccine|July 23, 2011
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced diseaseBeth-Ann G Coller, David E Clements, Andrew J Bett, et al.
Vaccines|December 23, 2020
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus DiseaseJoan G Tell, Beth-Ann G Coller, Sheri A Dubey, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 3, 2014
Advances in the understanding, management, and prevention of dengueLaura L Hermann, Swati B Gupta, Susan B Manoff, et al.
Vaccine|July 7, 2015
Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primatesDhanasekaran Govindarajan, Steven Meschino, Liming Guan, et al.
Viruses|March 27, 2025
Durability of Immunogenicity and Protection of rVSV∆G-ZEBOV-GP Vaccine in a Nonhuman Primate EBOV Challenge ModelSandra L Bixler, Amy C Shurtleff, Melek M E Sunay, et al.
The American Journal of Tropical Medicine and Hygiene|May 21, 2026
A Phase 1, Open Label, Safety Study of HBV-002 (West Nile Recombinant Subunit Vaccine) in Healthy AdultsBeth-Ann G Coller, David E Clements, Michele Yelmene, et al.
Vaccine|October 8, 2022
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trialsJakub K Simon, Stephen B Kennedy, Barbara E Mahon, et al.
Pageof 3